Understanding the epigenome and epitranscriptome in skin and cancer biology
The Capell Lab seeks to understand how epigenetic and epitranscriptomic gene regulatory mechanisms contribute to disease, and in particular, cancer. By combining the incredible accessibility of human skin with the most cutting-edge epigenetic and epitranscriptomic techniques, we aim to identify novel targets to treat disease.
We invite you to explore our website to learn more about our research program and its members.
Brian Capell, MD, PhD 2 days, 15 hours ago
Brian Capell, MD, PhD 3 days, 13 hours ago
Brian Capell, MD, PhD 5 days, 8 hours ago